Source: International Congress 2017 – Systemic and airway biomarkers
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
T. Southworth (Manchester, United Kingdom). Repeat Measurements of Complement proteins C3a and C5a in COPD patients. 1002

Member's Comments

No comment yet.

Related content which might interest you: Complement activation and exercise-induced asthma Source: Eur Respir J 2002; 20: Suppl. 38, 188s Year: 2002 Neutrophil elastase and IL-8 assessment in patients with COPD and asthma Source: Eur Respir J 2005; 26: Suppl. 49, 61s Year: 2005 Inflammatory mediators CRP, fibrinogen and leukocyte in stable COPD patients Source: Annual Congress 2007 - Airway regulation, provocation and monitoring I Year: 2007 Chemokine release by neutrophils in COPD Source: Annual Congress 2011 - Macrophages and neutrophils in chronic lung disease Year: 2011 Soluble RAGE is deficient in neutrophilic asthma and COPD Source: Eur Respir J 2012; 39: 721-729 Year: 2012 Leukotriene B4 receptor blockade increases apoptosis of monocyte-derived macrophages from patients with COPD and emphysema Source: Eur Respir J 2001; 18: Suppl. 33, 337s Year: 2001 Neutrophil activity assessed using a novel serological marker of human neutrophil elastase degraded calprotectin is elevated in patients with COPD or IPF Source: Virtual Congress 2021 – Advanced in vitro models for drug discovery Year: 2021 Bronchiectasis disease relevant PAMPs stimulate VEGF and neutrophil elastase release from neutrophils Source: International Congress 2017 – Novel mechanisms in asthma Year: 2017 Levels of proteinase 3 and neutrophil elastase in plasma, BAL and biopsies in COPD Source: Virtual Congress 2020 – Novel immunopathological mechanisms of lung disease: knowledge from translational studies Year: 2020 Variability of sputum inflammatory mediators in alpha-1-antitrypsin deficiency and usual COPD Source: Annual Congress 2011 - Bronchial hyperresponsiveness and exhaled and sputum biomarkers Year: 2011 Effects of CXCR2 antagonists on neutrophil chemotaxis from COPD patients Source: Annual Congress 2010 - Airway cells as targets for anti-inflammatory drugs Year: 2010 Relationship of circulating soluble urokinase plasminogen activator receptor (suPAR) levels to disease control in asthma and asthmatic pregnancy Source: International Congress 2014 – Systemic biomarkers for airway diseases Year: 2014 Chemotactic dynamics of COPD neutrophils Source: Annual Congress 2008 - Invasive and noninvasive measurements of lung inflammation Year: 2008 Usefulness of a selective neutrophil elastase inhibitor and a recombinant human soluble thrombomodulin in patients with ARDS and DIC Source: Annual Congress 2013 –Acute respiratory failure, ARDS and severe COPD exacerbations Year: 2013 Impaired monocyte chemotaxis in COPD Source: International Congress 2015 – Mucosal immunology: what’s new in 2015 Year: 2015 Conduct of a biomarker study in bronchiectasis patients: Correlation of neutrophil elastase activity and inflammatory load in induced sputum Source: International Congress 2014 – Systemic and airway biomarkers Year: 2014 Effect of JQ-1 on monocyte-derived macrophage (MDM) phagocytosis of bacteria and cytokine release Source: Annual Congress 2013 –Macrophages, mononuclear cells and viral infection Year: 2013 Soluble CD40 ligand and soluble P-selectin in allergic asthma patients during exercise-induced bronchoconstriction Source: Annual Congress 2007 - New mechanisms in the pathogenesis of asthma and allergy Year: 2007 Increased expression of sphingosine-1-phosphate and S1PR2 are associated with attenuated macrophage phagocytosis in COPD Source: Annual Congress 2013 –COPD: experimental biology Year: 2013 Neutrophil extracellular trap formation is regulated by CXCR2 in COPD neutrophils Source: Eur Respir J, 51 (4) 1700970; 10.1183/13993003.00970-2017 Year: 2018